Skip to main content
. 2018 May 2;7(1):51–58. doi: 10.1007/s40120-018-0095-y

Table 3.

Phase III Latrepirdine studies

Trial Formulation Adjunct Result
CONCERT Latrepirdine 5 mg Donepezil Fail
Latrepirdine 20 mg Donepezil Fail
CONNECTION Latrepirdine 5 mg Fail
Latrepirdine 20 mg Fail
CONSTELLATION Latrepirdine 20 mg Memantine Fail
CONTACT Latrepirdine 20 mg Donepezil Fail